Refine my results

Document type

Articles (9)

Institution

National (9)

Specific Collection

National Collections (9)

Language

English (9)

Author

Schwenkglenks, M. (9)
Szucs, T. (3)
Szucs, T.D. (3)
Blank, P.R. (2)
Lippuner, K. (2)
Ademi, Z. (1)
Blank, P. (1)
Brase, J. (1)
Brauchli, P. (1)
Caramuta, S. (1)
Dedes, K. J. (1)
Dubsky, P. (1)
Filipits, M. (1)
Früh, M. (1)
Gnant, M. (1)
Grifone, S. (1)
Gutzwiller, F. (1)
Imfeld, P. (1)
Jick, S. (1)
Joerger, M. (1)
Kronenwett, R. (1)
Kühnel, U. (1)
Linderholm, B.K. (1)
Loibl, S. (1)
Lux, M.P. (1)
Matter-Walstra, K. (1)
Matter-Walstra, K. W. (1)
Meier, Christoph (1)
Nekljudova, V. (1)
Perrelet, R. (1)

More Less

Domain

Medicine, Technology, Engineering (9)

Keyword

Epidemiology (2)
Osteoporosis (2)
Switzerland (2)
cost-effectiveness (2)
original articles (2)
Acute myocardial infarction (1)
Alendronate (1)
Bone densitometry (1)
Breast cancer (1)
Chronic lymphocytic leukaemia (1)
Chronic obstructive pulmonary disease (1)
Clinical spine fracture (1)
Cohort study (1)
Cost (1)
Cost-utility analysis (1)
Distal radius fracture (1)
Economics (1)
HER2 positive (1)
Heart failure (1)
Hip fracture (1)
Incidence (1)
Modelling studies (1)
Mortality (1)
Proximal humerus fracture (1)
Resource utilisation (1)
Stroke (1)
cetuximab (1)
chemoimmunotherapy (1)
cost-utility (1)
infection (1)

More Less

Refine my results

Document type

Institution

Specific Collection

Language

Author

Domain

Keyword

Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD)

Pfeil, A. ; Imfeld, P. ; Pettengell, R. ; Jick, S. ; Szucs, T. ; Meier, Christoph ; Schwenkglenks, M.

In: Annals of Hematology, 2015, vol. 94, no. 3, p. 421-429

Simulation-based cost-utility analysis of population screening-based alendronate use in Switzerland

Schwenkglenks, M. ; Lippuner, K.

In: Osteoporosis International, 2007, vol. 18, no. 11, p. 1481-1491

Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons

Blank, P. ; Schwenkglenks, M. ; Szucs, T.

In: Infection, 2009, vol. 37, no. 5, p. 390-400

Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008

Lippuner, K. ; Grifone, S. ; Schwenkglenks, M. ; Schwab, P. ; Popp, A. ; Senn, C. ; Perrelet, R.

In: Osteoporosis International, 2012, vol. 23, no. 3, p. 829-839

45PCost-effectiveness analysis of VEGF-A testing to predict response to bevacizumab (BEV) as a component of neo-adjuvant therapy of early HER-2 negative breast cancer

Blank, P.R. ; Loibl, S. ; Linderholm, B.K. ; Caramuta, S. ; Nekljudova, V. ; Szucs, T.D. ; Van Stiphout, J. ; Ademi, Z. ; von Minckwitz, G. ; Schwenkglenks, M.

In: Annals of Oncology, 2015, vol. 26, p. iii16-iii17

Trastuzumab beyond progression: a cost-utility analysis

Matter-Walstra, K. W. ; Dedes, K. J. ; Schwenkglenks, M. ; Brauchli, P. ; Szucs, T. D. ; Pestalozzi, B. C.

In: Annals of Oncology, 2010, vol. 21, no. 11, p. 2161-2168

Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Joerger, M. ; Matter-Walstra, K. ; Früh, M. ; Kühnel, U. ; Szucs, T. ; Pestalozzi, B. ; Schwenkglenks, M.

In: Annals of Oncology, 2011, vol. 22, no. 3, p. 567-574

Determinants of costs and resource utilization associated with open heart surgery

Sokolovic, E. ; Schmidlin, D. ; Schmid, E.R. ; Turina, M. ; Ruef, C. ; Schwenkglenks, M. ; Szucs, T.D.

In: European Heart Journal, 2002, vol. 23, no. 7, p. 574-578

59PHEALTH ECONOMIC ANALYSIS OF GUIDELINE AND GENE EXPRESSION SIGNATURE-BASED RISK STRATIFICATION OF DISTANT RECURRENCE IN EARLY BREAST CANCER PATIENTS

Blank, P.R. ; Schwenkglenks, M. ; Dubsky, P. ; Filipits, M. ; Gutzwiller, F. ; Lux, M.P. ; Brase, J. ; Kronenwett, R. ; Szucs, T.D. ; Gnant, M.

In: Annals of Oncology, 2013, vol. 24, p. iii31-iii31